NCT05222555 2026-01-16
MINDway
Incyte Corporation
Phase 1/2 Active not recruiting
Clinical Trials
5 trialsNCT02763319 2025-07-17
B-MIND
Incyte Corporation
Phase 2/3 Completed
NCT04134936 2024-10-16
Phase Ib Study to Assess Safety and Preliminary Efficacy of Tafasitamab or Tafasitamab Plus Lenalidomide in Addition to R-CHOP in Patients With Newly Diagnosed DLBCL
MorphoSys AG
Phase 1 Completed
NCT05328102 2024-04-30
Phase 2 Study of Plamotamab Combined With Tafasitamab Plus Lenalidomide Versus Tafasitamab Plus Lenalidomide in Relapsed or Refractory (R/R) Diffuse Large-cell B-cell Lymphoma (DLBCL)
Xencor, Inc.
Phase 2 Terminated
NCT02399085 2023-10-23
L-MIND
MorphoSys AG
Phase 2 Completed